CRP and acute lymphoblastic leukemia: Immunepotent CRP (ICRP), a bovine dialyzable leukocyte extract, displays selective cytotoxicity against several solid and hematologic cancers by inducing ROS-dependent apoptosis in T-cell acute lymphoblastic leukemia (T-ALL) cells, leading to nuclear and mitochondrial damage [20,26].